Xenon further strengthens balance sheet with $63M follow-on

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel.

The price is a 2% discount to Xenon's closing price of $14.25 on Sept. 12, when it proposed the offering after market hours. Xenon was down $0.30 to $13.95 on Sept. 13...